Cancer cachexia: mediators, signaling, and metabolic pathways
KCH Fearon, DJ Glass, DC Guttridge - Cell metabolism, 2012 - cell.com
Cancer cachexia is characterized by a significant reduction in body weight resulting
predominantly from loss of adipose tissue and skeletal muscle. Cachexia causes reduced …
predominantly from loss of adipose tissue and skeletal muscle. Cachexia causes reduced …
Prognostication in advanced cancer: update and directions for future research
The objective of this review is to provide an update on prognostication in patients with
advanced cancer and to discuss future directions for research in this field. Accurate …
advanced cancer and to discuss future directions for research in this field. Accurate …
ESPEN practical guideline: Clinical Nutrition in cancer
M Muscaritoli, J Arends, P Bachmann, V Baracos… - Clinical Nutrition, 2021 - Elsevier
Background This practical guideline is based on the current scientific ESPEN guidelines on
nutrition in cancer patients. Methods ESPEN guidelines have been shortened and …
nutrition in cancer patients. Methods ESPEN guidelines have been shortened and …
[HTML][HTML] Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines☆
Cachexia remains an underdiagnosed and undertreated, complex condition which includes
'objective'components (eg inadequate food intake, weight loss, inactivity, loss of muscle …
'objective'components (eg inadequate food intake, weight loss, inactivity, loss of muscle …
Management of cancer cachexia: ASCO guideline
EJ Roeland, K Bohlke, VE Baracos, E Bruera… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE To provide evidence-based guidance on the clinical management of cancer
cachexia in adult patients with advanced cancer. METHODS A systematic review of the …
cachexia in adult patients with advanced cancer. METHODS A systematic review of the …
ESPEN guidelines on nutrition in cancer patients
J Arends, P Bachmann, V Baracos, N Barthelemy… - Clinical nutrition, 2017 - Elsevier
Cancers are among the leading causes of morbidity and mortality worldwide, and the
number of new cases is expected to rise significantly over the next decades. At the same …
number of new cases is expected to rise significantly over the next decades. At the same …
A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer
Background Cancer cachexia is a syndrome of weight loss (including muscle and fat),
anorexia, and decreased physical function. It has been suggested that the optimal treatment …
anorexia, and decreased physical function. It has been suggested that the optimal treatment …
Cancer cachexia: rationale for the MENAC (Multimodal—Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial
Cancer cachexia is a multifactorial syndrome characterised by an ongoing loss of skeletal
muscle mass that cannot be fully reversed by conventional nutritional support alone …
muscle mass that cannot be fully reversed by conventional nutritional support alone …
The last days of life: symptom burden and impact on nutrition and hydration in cancer patients
D Hui, R Dev, E Bruera - … opinion in supportive and palliative care, 2015 - journals.lww.com
The last days of life: symptom burden and impact on nutritio... : Current Opinion in Supportive
and Palliative Care The last days of life: symptom burden and impact on nutrition and hydration …
and Palliative Care The last days of life: symptom burden and impact on nutrition and hydration …
Integration of palliative, supportive, and nutritional care to alleviate eating-related distress among advanced cancer patients with cachexia and their family members
K Amano, VE Baracos, JB Hopkinson - Critical Reviews in Oncology …, 2019 - Elsevier
Advanced cancer patients with cachexia and their families can suffer from eating-related
distress. This complex entity encompasses patients' struggle to nourish themselves …
distress. This complex entity encompasses patients' struggle to nourish themselves …